Which test would you like to explore?

The Only 3-Gas Breath Test for Identifying All 3 Types of SIBO

Trio-Smart breath test, collection bag, and mouthpiece with results displayed on a smartphone.

Learn more at:

TrioSmartBreath.com

The At-Home Test for Post-Infectious IBS (PI-IBS)

IBS-Smart kit with Tasso device for blood collection

Learn more at:

IBSSmart.com

Key
Partnerships

Gemelli Biotech collaborates with leading scientific, medical, and international laboratory partners to advance access to its precision microbiome diagnostics. These partnerships, from Cedars-Sinai’s Medically Associated Science and Technology (MAST) program to global clinical labs, support innovation and worldwide availability of clinically validated diagnostic solutions.

Medically Associated Science & Technology

Medically Associated Science and Technology (MAST) LogoCedars-Sinai logo

Gemelli Biotech is proud to partner closely with the Medically Associated Science and Technology (MAST) program at Cedars-Sinai in Los Angeles, ranked by US News and World Report as one of the top 10 hospitals in the nation. MAST is dedicated to the development of diagnostics and therapeutics for conditions of the microbiome.

Partnership with MAST allows Gemelli to operate on the cutting edge, with an early look at the newest scientific discoveries related to the microbiome.

Learn More About MAST
MAST Program at Cedars-Sinai hospital in Los Angeles, California.

In the News

Launch of IBS-Smart, an advancement in blood testing for Irritable Bowel Syndrome (IBS) announced by Gemelli Biotech in partnership with the Medically Associated Science and Technology Program (MAST) at Cedars-Sinai

Gemelli Biotech, a specialty biotechnology company focused on developing novel diagnostics and therapeutics for the human microbiome, announced the commercial availability of IBS-Smart, a second-generation blood test for Irritable Bowel Syndrome (IBS). IBS-Smart offers an advancement in the specificity and accuracy of measuring two antibodies (anti-CdtB and anti-vinculin) in diagnosing Diarrhea Predominant and Mixed-Type IBS (IBS-D and IBS-M).

Read More